BioNexus Gene Lab Statistics

NASDAQ: BGLCHealth CareMedical SpecialitiesUSD

1.33-0.021 (-1.56%)

Market open · Delayed 15 min · as of Oct 8, 9:36 AM ET

BioNexus Gene Lab by the numbers

BioNexus Gene Lab has a market capitalization of $3.9 million based on 2.93M shares outstanding. With trailing EPS of $-1.26, BioNexus Gene Lab is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.4% below its 50-day average and 39.7% below its 200-day average.

Average daily trading volume is 11.08K shares, or about $14,689 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BGLC valuation vs. peer median

BGLC compared with the median of 8 peer companies
Metric	BGLC	Peer median	Difference
Market cap	$3.89M	$44.71M	-91%
Avg. volume	11.08K	40.70K	-73%

Peer median across 8 companies: ACON, AMS, ADVB, ACH, MDXH, SERA, KEQU, BNR.

Valuation

Market cap: $3.89M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-1.26
Shares outstanding: 2.93M

Price and trading

Previous close: 1.35
Open: 1.33
Day range: 1.33 – 1.33
52-week range: 1.07 – 5.89
50-day moving average: 1.46
200-day moving average: 2.20
Beta: —
Volume: 1.06K
Average volume: 11.08K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 3.89M
Eps: -1.26
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 5.89
Week52 Low: 1.07
Avg Volume: 11,079.00
Shares Outstanding: 2.93M
Ma50: 1.46
Ma200: 2.20
Pct From52w High: -77.48%
Pct From52w Low: 23.91%